Detection of surfactant proteins A, B, C, and D in human nasal mucosa and their regulation in chronic rhinosinusitis with polyps

American Journal of Rhinology and Allergy

Volumn 27, Issue 1, 2013, Pages 24-29

  Schicht, Martin ^a   Knipping, Stephan ^b   Hirt, Roman ^b   Beileke, Stephanie ^c   Sel, Saadettin ^a   Paulsen, Friedrich ^a   Bräuer, Lars ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b DESSAU MEDICAL CENTER   (Germany)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MONOCLONAL ANTIBODY; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; SURFACTANT PROTEIN D;

ADOLESCENT; ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; CHRONIC RHINOSINUSITIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; NOSE MUCOSA; NOSE POLYP; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; CHRONIC DISEASE; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NASAL POLYPS; PROTEIN PRECURSORS; PROTEOLIPIDS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN C; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHINITIS; SINUSITIS; YOUNG ADULT;

EID: 84876050559     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2013.27.3838     Document Type: Article

References (43)

1. Corbo DC, Liu JC, and Chien YW. Characterization of the barrier properties of mucosal membranes. J Pharm Sci 79:202-206, 1990.
2. Cornaz A-L, and Buri P. Nasal mucosa as an absorption barrier. Eur J Pharm Biopharm 40:261-270, 1994.
3. Terrahe K. Die Drǔ sen der respiratorischen Nasenschleimhaut. Verǒffentlichungen aus der morphologischen. Pathologie Stuttgart, Fischer-Verl, Morphol Path 81:1-86, 1970.
4. Knipping S, Holzhausen HJ, Riederer A, and Schrom T. Allergic and idiopathic rhinitis: An ultrastructural study. Eur Arch Otorhinolaryngol 266:1249-1256, 2009.
5. Breuninger H. U? ber das physikalisch-chemische Verhalten des Nasenschleims. Arch Ohr Nas Kehlk Heilk 184:133-138, 1964.
6. Th. D. Physiology and pathology of the mucociliary system. Adv Otorhinolaryngol 43:281-288, 1983.
7. Casado B, Pannell LK, Iadarola P, and Baraniuk JN. Identification of human nasal mucous proteins using proteomics. Proteomics 5:2949- 2959, 2005.
8. Baraniuk JN. In lasley, m. V., altman, l. C. (Eds). Immunol Allergy Clin North Am pp. 245-264, 2000.
9. Lindahl M, Irander K, Tagesson C, and Stahlbom B. Nasal lavage fluid and proteomics as means to identify the effects of the irritating epoxy chemical dimethylbenzylamine. Biomarkers: Biochemical indicators of exposure, response, and susceptibility to chemicals. 9:56- 70, 2004.
10. Kim JK, Kim SS, Rha KW, et al. Expression and localization of surfactant proteins in human nasal epithelium. Am J Physiol Lung Cell Mol Physiol 292:L879-L884, 2007.
11. Crouch E, and Wright Jr. Surfactant proteins a and d and pulmonary host defense. Ann Rev Physiol 63:521-554, 2001.
12. Yu SH, and Possmayer F. Role of bovine pulmonary surfactantassociated proteins in the surface-active property of phospholipid mixtures. Biochim Biophys Acta 1046:233-241, 1990.
13. Wright Jr. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol 5:58-68, 2005.
14. Wetering JK, Golde L, and Batenburg JJ. Collectins - Players of the innate immune system. Eur J Biochem 271:1229-1249, 2004.
15. Kishore U, Greenhough T, Waters P, et al. Surfactant proteins sp-A and sp-d: Structure, function and receptors. Mol Immunol 43:1293- 1315, 2006.
16. Bourbon JR, and Chailley-Heu B. Surfactant proteins in the digestive tract, mesentery, and other organs: Evolutionary significance. Comp Biochem Physiol 129:151-161, 2001.
17. Brǎuer L, Kindler C, Jǎger K, et al. Detection of surfactant proteins a and d in human tear fluid and the human lacrimal system. Invest Ophthalmol Vis Sci 48:3945-3953, 2007.
18. Brǎuer L, Mǒschter S, Beileke S, et al. Human parotid and submandibular glands express and secrete surfactant proteins a, b, c and d. Histochem Cell Biol 132:331-338, 2009.
19. Brǎuer L, Schicht M, Stengl C, et al. Detection of surfactant proteins a, b, c and d in human gingiva and saliva. Biomed Tech (Berl) 57:59-64, 2012.
20. Curstedt T, Johansson J, Barros-Soderling J, et al. Low-molecularmass surfactant protein type 1. The primary structure of a hydrophobic 8-kda polypeptide with eight half-cystine residues. Eur J Biochem FEBS 172:521-525, 1988.
21. Notter RH, Shapiro DL, Ohning B, and Whitsett JA. Biophysical activity of synthetic phospholipids combined with purified lung surfactant 6000 dalton apoprotein. Chem Phys Lipids 44:1-17, 1987.
22. Brǎuer L, Johl M, Bǒrgermann J, et al. Detection and localization of the hydrophobic surfactant proteins b and c in human tear fluid and the human lacrimal system. Curr Eye Res 32:931-938, 2007.
23. Paananen R, Glumoff V, Sormunen R, et al. Expression and localization of lung surfactant protein b in eustachian tube epithelium. Am J Physiol Lung Cell Mol Physiol 280:L214-L220, 2001.
24. Fokkens W, Lund V, Mullol J and European Position Paper on Rhinosinusitis and Nasal Polyps group. European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl 20:1-136, 2007.
25. Benson DA, Karsch-Mizrachi I, Lipman DJ, et al. Genbank. Nucleic Acids Res 34:D16-D20, 2006.
26. Ooi EH, Wormald PJ, Carney AS, et al. Surfactant protein d expression in chronic rhinosinusitis patients and immune responses in vitro to aspergillus and Alternaria in a nasal explant model. Laryngoscope 117:51-57, 2007.
27. Schlosser RJ. Surfactant and its role in chronic sinusitis. Ann Otology Rhinol Laryngol Suppl 196:40-44, 2006.
28. Woodworth BA, Wood R, Bhargave G, et al. Surfactant protein b detection and gene expression in chronic rhinosinusitis. Laryngoscope 117:1296-1301, 2007.
29. Whitsett JA, Hull WM, Ohning B, et al. Immunological identification of a pulmonary surfactant-associated protein of molecular-weight - 6000 daltons. Pediatr Res 20:744-749, 1986.
30. Voorhout WF, Veenendaal T, Haagsman HP, et al. Intracellular processing of pulmonary surfactant protein b in an endosomal/lysosomal compartment. Am J Physiol 263:479-486, 1992.
31. Paulsen F, Langer G, Hoffmann W, and Berry M. Human lacrimal gland mucins. Cell Tissue Res 316:167-177, 2004.
32. LeVine AM, Whitsett JA, Hartshorn KL, et al. Surfactant protein d enhances clearance of influenza a virus from the lung in vivo. J Immunol 167:5868-5873, 2001.
33. Balachandran P, Brooks-Walter A, Virolainen-Julkunen A, et al. Role of pneumococcal surface protein c in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of streptococcus pneumoniae. Infect Immun 70:2526-2534, 2002.
34. Wootten CT, Labadie RF, Chen A, and Lane KF. Differential expression of surfactant protein a in the nasal mucosa of patients with allergy symptoms. Arch Otolaryngol Head Neck Surg 132:1001-1007, 2006.
35. Seong JK, Koo JS, Lee WJ, et al. Upregulation of muc8 and downregulation of muc5ac by inflammatory mediators in human nasal polyps and cultured nasal epithelium. Acta Otolaryngol 122:401-407, 2002.
36. Hsu J, and Peters AT. Pathophysiology of chronic rhinosinusitis with nasal polyp. Am J Rhinol Allergy 25:285-290, 2011.
37. Oberley RE, Goss KL, Dahmoush L, et al. A role for surfactant protein d in innate immunity of the human prostate. Prostate 65:241-251, 2005.
38. Robin M, Dong P, Hermans C, et al. Serum levels of cc16, sp-A and sp-b reflect tobacco-smoke exposure in asymptomatic subjects. Eur Respir J 20:1152-1161, 2002.
39. Glasser SW, Burhans MS, Korfhagen TR, et al. Altered stability of pulmonary surfactant in sp-c-deficient mice. Proc Natl Acad Sci U S A 98:6366-6371, 2001.
40. Nogee LM, Dunbar AE III, Wert SE, et al. A mutation in the surfactant protein c gene associated with familial interstitial lung disease. New Engl J Med 344:573-579, 2001.
41. Glowina A. Das Surfactant-Sytem. Ein neuer Therapieansatz fǔ r die Schleimhaut der oberen Atemwege. Atemwegs Lungenkrankheiten 31(suppl):1-5, 2011.
42. Weston LA, and Moesges R. Treating seasonal allergic rhinoconjunctivitis with a liposomal nasal spray. Allergologie 33:196-204, 2010.
43. Salman S, Akpinar ME, Yigit O, and Gormus U. Surfactant protein a and d in chronic rhinosinusitis with nasal polyposis and corticosteroid response. Am J Rhinol Allergy 26:e76-e80, 2012.